» Articles » PMID: 21506690

Disulfide Reduction in the Endocytic Pathway: Immunological Functions of Gamma-interferon-inducible Lysosomal Thiol Reductase

Overview
Specialty Endocrinology
Date 2011 Apr 22
PMID 21506690
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Gamma-interferon-inducible lysosomal thiol reductase (GILT) is constitutively expressed in most antigen presenting cells and is interferon γ inducible in other cell types via signal transducer and activator of transcription 1. Normally, N- and C-terminal propeptides are cleaved in the early endosome, and the mature protein resides in late endosomes and lysosomes. Correspondingly, GILT has maximal reductase activity at an acidic pH. Monocyte differentiation via Toll-like receptor 4 triggers secretion of a disulfide-linked dimer of the enzymatically active precursor, which may contribute to inflammation. GILT facilitates major histocompatibility complex (MHC) class II-restricted processing through reduction of protein disulfide bonds in the endocytic pathway and is hypothesized to expose buried epitopes for MHC class II binding. GILT can also facilitate the transfer of disulfide-containing antigens into the cytosol, enhancing their cross-presentation by MHC class I. A variety of antigens are strongly influenced by GILT-mediated reduction, including hen egg lysozyme, melanocyte differentiation antigens, and viral envelope glycoproteins. In addition, GILT is conserved among lower eukaryotes and likely has additional functions. For example, GILT expression increases the stability of superoxide dismutase 2 and decreases reactive oxygen species, which correlates with decreased cellular proliferation. It is also a critical host factor for infection with Listeria monocytogenes.

Citing Articles

Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers.

Zhang S, Ren L, Li W, Zhang Y, Yang Y, Yang H Cell Oncol (Dordr). 2024; 47(5):1593-1605.

PMID: 39141317 DOI: 10.1007/s13402-024-00979-x.


NCF4 regulates antigen presentation of cysteine peptides by intracellular oxidative response and restricts activation of autoreactive and arthritogenic T cells.

Xu J, He C, Cai Y, Wang X, Yan J, Zhang J Redox Biol. 2024; 72:103132.

PMID: 38547647 PMC: 11096609. DOI: 10.1016/j.redox.2024.103132.


Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer.

Liu X, Sun K, Yang H, Zou D, Xia L, Lu K Heliyon. 2024; 10(4):e25643.

PMID: 38420434 PMC: 10900431. DOI: 10.1016/j.heliyon.2024.e25643.


mosGILT controls innate immunity and germ cell development in Anopheles gambiae.

Arora G, Tang X, Cui Y, Yang J, Chuang Y, Joshi J BMC Genomics. 2024; 25(1):42.

PMID: 38191283 PMC: 10775533. DOI: 10.1186/s12864-023-09887-0.


Ultra High-plex Spatial Proteogenomic Investigation of Giant Cell Glioblastoma Multiforme Immune Infiltrates Reveals Distinct Protein and RNA Expression Profiles.

Bonnett S, Rosenbloom A, Ong G, Conner M, Rininger A, Newhouse D Cancer Res Commun. 2023; 3(5):763-779.

PMID: 37377888 PMC: 10155752. DOI: 10.1158/2767-9764.CRC-22-0396.


References
1.
Phan U, Arunachalam B, Cresswell P . Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J Biol Chem. 2000; 275(34):25907-14. DOI: 10.1074/jbc.M003459200. View

2.
Lackman R, Cresswell P . Exposure of the promonocytic cell line THP-1 to Escherichia coli induces IFN-gamma-inducible lysosomal thiol reductase expression by inflammatory cytokines. J Immunol. 2006; 177(7):4833-40. DOI: 10.4049/jimmunol.177.7.4833. View

3.
Seliger B, Ritz U, Abele R, Bock M, Tampe R, Sutter G . Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res. 2001; 61(24):8647-50. View

4.
Jensen P . Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant. J Exp Med. 1991; 174(5):1121-30. PMC: 2119004. DOI: 10.1084/jem.174.5.1121. View

5.
Robila V, Ostankovitch M, Altrich-Vanlith M, Theos A, Drover S, Marks M . MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes. J Immunol. 2008; 181(11):7843-52. PMC: 2659719. DOI: 10.4049/jimmunol.181.11.7843. View